Hangzhou, Zhejiang, China | Fund Name | Location |
| Carbon Black | Massachusetts, United States, Waltham |
| Cedar Grove Investments | Seattle, United States, Washington |
| Dassault Systemes | France, Ile-de-France, Vélizy-villacoublay |
| Efficient Capacity fund | California, San Francisco, United States |
| Elite Capital | China, Shanghai |
| J12 Ventures | Stockholm, Stockholm County, Sweden |
| NO/LA Angel Network | Louisiana, New Orleans, United States |
| Northern Film and Media | England, Gateshead, United Kingdom |
| Pureos Bioventures | Küsnacht, Switzerland, Zurich |
| RITEK Corporation | China, Jiangsu, Taiwan |
| Setouchi Kanko Kasseika Fund | - |
| Sistema SmartTech | - |
| SKS PE | Seoul, Seoul-t'ukpyolsi, South Korea |
| Stobart Group | England, Germany, Nordrhein-Westfalen |
| Tao Tsuot | HaMerkaz, Israel, Petah Tiqva |
| Tri-Valley Ventures | California, Pleasanton, United States |
| Ventureworks India | India, Maharashtra, Mumbai |
| Vorwerk Direct Selling Ventures | Berlin, Berlin, Germany |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Percans Oncology | $7M | 01 Feb 2017 | Changping District, Beijing, China |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Percans Oncology | $7M | 01 Feb 2017 | Changping District, Beijing, China |
